Patent details

EP3539542 Title: DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH A THROMBOLYTIC

Basic Information

Publication number:
EP3539542
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191658053
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH A THROMBOLYTIC
French Title of Invention:
COMPOSÉS AMÉLIORANT LA DIFFUSION ET LEUR UTILISATION AVEC UN THROMBOLITIQUE
German Title of Invention:
VERTEILUNGSVERBESSERTE VERBINDUNGEN UND IHRE VERWENDUNG MIT EINEM THROMBOLYTICUM
SPC Number:

Dates

Filing date:
22/06/2010
Grant date:
19/04/2023
EP Publication Date:
18/09/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/04/2023
EP B1 Publication Date:
19/04/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/06/2023
Expiration date:
22/06/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/04/2023
 
 

Name:
Diffusion Pharmaceuticals LLC
Address:
1317 Carlton Avenue, Suite 200, Charlottesville, Virginia 22902, United States (US)

Inventor

Name:
Gainer, John L.
Address:
United States (US)

Priority

Priority Number:
21357509 P
Priority Date:
22/06/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/202; A61K 38/48; A61P 9/10; A61K 31/724; A61K 31/203;

Publication

European Patent Bulletin

Issue number:
202316
Publication date:
19/04/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages